Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateDistrict of ColumbiaHearing Scheduled
B 260606: Vaccine Administration Protection Amendment Act of 2026
Phil Mendelson
B 260606 status: Hearing Scheduled — Public Hearing on B26-0606 (updated Sep 24, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
72OUT OF 100
Score:72/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 65/100
Constitutionality90%
Bipartisan70%
Public opinion75%
Bill summary
This bill, currently being considered by the D.C. Council, would make it easier for more healthcare workers (such as pharmacists) to give vaccines. It also provides these workers with legal protection, as long as they follow the required safety rules. In short: It’s designed to expand vaccine access and protect the people who administer them.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
65%
Benefits
- Increased service capacity for community pharmacies
- Optimized labor utilization for healthcare facilities
- Potential revenue growth for pharmacy sector
Risks
- New training cost burden for pharmacy employers
- Potential adjustment needs for liability insurance
- Increased administrative overhead for compliance tracking
Society
Positive outlook
75%
Benefits
- Improved health access for residents in underserved areas
- Reduced barriers to routine preventative care
- Increased convenience for vaccine-seekers
Risks
- Public trust concerns regarding non-traditional clinical settings
- Potential variance in patient counseling quality
- Risk of logistical strain during high-demand periods
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Positive outlook
75%
Benefits
- Faster vaccine rollout capacity during health surges
- Wider reach for immunization programs across the District
- Lower threshold for routine healthcare interactions
Risks
- Potential challenges in managing acute adverse reactions
- Reliance on standard protocols across different facility types
- Increased oversight needs during rapid immunization scaling
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Legal protection is conditional; workers must strictly adhere to safety rules which remain undefined in this summary.
Analysis scope
Source provided is a brief abstract; full bill text is unavailable.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.